spironolactone has been researched along with Familial Turner Syndrome in 1 studies
Spironolactone: A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
spironolactone : A steroid lactone that is 17alpha-pregn-4-ene-21,17-carbolactone substituted by an oxo group at position 3 and an alpha-acetylsulfanyl group at position 7.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We report successful diuretics treatment with spironolactone and furosemide at standard dose, of refractory PLE in a patient with Noonan syndrome and repaired congenital heart disease." | 3.81 | Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome. ( Iemura, M; Kudo, Y; Matsuishi, T; Mizuochi, T; Seki, Y; Suda, K; Tanikawa, K; Yanagi, T; Yoshimoto, H, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizuochi, T | 1 |
| Suda, K | 1 |
| Seki, Y | 1 |
| Yanagi, T | 1 |
| Yoshimoto, H | 1 |
| Kudo, Y | 1 |
| Iemura, M | 1 |
| Tanikawa, K | 1 |
| Matsuishi, T | 1 |
1 other study available for spironolactone and Familial Turner Syndrome
| Article | Year |
|---|---|
Successful diuretics treatment of protein-losing enteropathy in Noonan syndrome.
Topics: Child; Diuretics; Female; Fontan Procedure; Furosemide; Heart Defects, Congenital; Humans; Noonan Sy | 2015 |